Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, Cytokinetics Inc (NASDAQ: CYTK) closed at $30.28 down -0.82% from its previous closing price of $30.53. In other words, the price has decreased by -$0.82 from its previous closing price. On the day, 1.11 million shares were traded.
Ratios:
For a deeper understanding of Cytokinetics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.99 and its Current Ratio is at 5.99.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Barclays on April 24, 2025, initiated with a Overweight rating and assigned the stock a target price of $55.
On February 07, 2025, Citigroup started tracking the stock assigning a Buy rating and target price of $86.
On January 22, 2025, Stifel started tracking the stock assigning a Buy rating and target price of $80.Stifel initiated its Buy rating on January 22, 2025, with a $80 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on May 20 ’25 when Malik Fady Ibraham sold 2,000 shares for $31.98 per share. The transaction valued at 63,960 led to the insider holds 140,255 shares of the business.
Blum Robert I sold 5,000 shares of CYTK for $154,650 on May 16 ’25. The President & CEO now owns 412,629 shares after completing the transaction at $30.93 per share. On May 15 ’25, another insider, Bhanji Muna, who serves as the Director of the company, sold 1,454 shares for $29.73 each. As a result, the insider received 43,227 and left with 23,510 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 188.15.
Stock Price History:
Over the past 52 weeks, CYTK has reached a high of $61.38, while it has fallen to a 52-week low of $29.31. The 50-Day Moving Average of the stock is -19.10%, while the 200-Day Moving Average is calculated to be -36.30%.
Shares Statistics:
A total of 119.22M shares are outstanding, with a floating share count of 116.74M. Insiders hold about 2.25% of the company’s shares, while institutions hold 116.09% stake in the company.
